Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prospective comparative study of the efficacy of acupuncture versus conventional treatment for the management of chronic pain in patients with chronic kidney disease receiving conservative treatment or renal replacement therapy (Peritoneal dialysis or hemodialysis)

NCT ID NCT07891819

Sponsor: Federal University of São Paulo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 23, 2026 · Last updated Oct 23, 2026

Summary

This study evaluated acupuncture plus optimized conventional pharmacological treatment compared with optimized conventional pharmacological treatment alone for chronic pain in adults with chronic kidney disease receiving conservative treatment, peritoneal dialysis, or hemodialysis. The study was conducted prospectively at a single center. Actual allocation was not exclusively randomized because some participants who expressed a preference for acupuncture before allocation were assigned to the acupuncture group, while the planned random sequence was used for participants without an expressed preference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

110 people

The number who actually took part.

Started

Sep 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 75 years, of either sex * Chronic pain lasting more than 3 months * Pain intensity of at least 6 on a 0-to-10 visual analog scale (VAS) at the allocation visit (V2) * Chronic kidney disease managed with conservative treatment or receiving renal replacement therapy with peritoneal dialysis or hemodialysis * Signed informed consent Exclusion Criteria: * Pregnancy * Inability to understand study instructions, attend study visits, or complete the assessment scales * History of alcohol or drug abuse * Psychological or emotional disorders considered likely to invalidate informed consent or limit adherence to study procedures * Coagulation disorders * Allergy to commonly used analgesic medications * Recommendation to discontinue nonsteroidal anti-inflammatory drugs (NSAIDs)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Chronic Pain chronic pain syndrome chronic renal failure syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Neuralgia Renal insufficiency,chronic

Contacts and locations

Locations

  • Hospital do Rim

    São Paulo, São Paulo, 05078-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.